Introduction {#sec1}
============

Powerful screening analytic techniques are key tools in a successful catalyst design, development, and optimization study. Today, the majority of screening techniques in the field of catalysis are based on NMR, high-performance liquid chromatography (HPLC), or gas chromatography (GC) methodology.^[@ref1]^ Occasionally, however, discrepancies between the results obtained by these methods are observed. Whether these are inflicted by byproducts, their signals overlapping with those of the compounds being used for analysis (products, substrates, or internal references) or by other inherent pitfalls, a complimentary technique based on a different analytical principle can constitute a true benefit in these cases. Moreover, screening techniques bearing potential for parallel evaluation are beneficial in terms of time-economy, when compared with those described above, which must be usually applied in a sequential manner.^[@ref2]^

Recently, we became interested in developing an organocatalytic system for an asymmetric Robinson annulation, particularly for this reaction variant involving a simple ketone, serving as a nucleophile at both steps of annulation. The Robinson annulation reaction is a well-known cascade process, initiated by an intermolecular Michael addition, which is then succeeded by an intramolecular aldol condensation.^[@ref3]^ Cascade processes foster an increase in synthetic efficiency by decreasing the number of laboratory operations and chemicals at use, in addition to avoiding time-consuming protecting group manipulations and isolation of reaction intermediates. Specifically, the popular Robinson annulation domino sequence could be utilized as a convenient method for obtaining asymmetric cyclohexenone derivatives, which are of great value for the synthesis of many natural products, antibiotics, and steroids,^[@ref4]^ and otherwise require more complex synthetic routes for their assembly.

Most frequently, this transformation involves a 1,3-dicarbonyl or a related compound and an alkenyl-alkyl ketone (methyl vinyl ketone or its substituted analogues),^[@ref5]^ which act as a nucleophile and an electrophile, respectively, at the intermolecular step of the reaction ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}a). At the intramolecular step, the roles of the components originating from the two substrates are reversed, that is, the alkyl substituent of the former enone turns into a nucleophile, attacking one of the carbonyls of the former dicarbonyl compound. Occasionally, ketones or aldehydes are used instead of dicarbonyls, without a significant change in the mechanism of the reaction ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}b).^[@ref6]^ In a less common, but still relatively abundant, case, a dicarbonyl compound reacts with an enone lacking an enolizable alkyl substituent (e.g., chalcone) and provides two nucleophilic centers, one for the Michael addition step and one for the subsequent aldol condensation ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}c).^[@ref7],[@ref8]^ On the other hand, the variant of the Robinson annulation that involves a simple dialkyl ketone and a chalcone or other enone without an α-to-carbonyl enolizable group, and hence requires the two α carbons of the ketone to act as nucleophiles at both steps of the cascade, is rare ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}d).^[@ref9]−[@ref11]^ Moreover, although it was already demonstrated over 40 years ago that organocatalysts, [l]{.smallcaps}-proline in particular, are viable for enantioselectively conducting the regular one-pot Robinson annulation reactions,^[@ref12],[@ref13]^ an enantioselective version of the particular annulation variant, involving a ketone and a nonenolizable enone, has been reported only this year.^[@cit9c]^

![Different variants of the Robinson annulation: abundant (a--c) as well as a rare variant described in this work (d). Red dots mark the carbons acting as nucleophiles, whereas blue dots mark those acting as electrophiles.](ao-2017-01103r_0005){#fig1}

Recently, we observed that PS([l]{.smallcaps}-Val-DPEN), a chiral bifunctional polystyrene (PS)-bound organocatalyst, originally designed for an asymmetric nitro-Michael addition reaction,^[@ref14]^ promotes the asymmetric Robinson annulation reaction between chalcone and acetone with promising enantioselectivity but poor yield. According to ^1^H NMR analysis, as much as 30 molar % of the catalyst gave a disappointing 13% yield ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). Although HPLC analysis provided the enantiomeric excess (ee), there was a certain discrepancy in the yield estimation of the reaction by HPLC compared to that by NMR analysis. At this point, we decided to develop a fluorogenic assay as an additional method for analyzing the efficiency of the catalysts in this reaction. Offering extremely high sensitivity, fluorescence measurements have recently gained great momentum as one of the methods enabling the detection and quantification of the product acquired in a catalytic reaction.^[@ref15]^ Consequently, generating a fluorophore-incorporating product in methodology development is useful for analytical purposes, with both standard fluorescence measurement and fluorescence detection in liquid chromatography available as analytical methods.^[@ref16]^ We presumed that such a technique would allow easy and expedient evaluation of the reaction yield, deliver the desired information with a higher sensitivity, and would therefore provide a convenient screening process for different catalysts, particularly in a parallel fashion.

![Asymmetric Robinson Annulation Reaction between Chalcone and Acetone, Promoted by a Bifunctional Polystyrene-Bound Catalyst^,^\
Reaction conditions: chalcone (1 equiv), acetone (30 equiv), PS([l]{.smallcaps}-Val-DPEN) (0.3 equiv), benzoic acid (0.2 equiv), toluene, 75 °C, 4 days.\
The absolute configuration of the stereogenic center was never determined, thus, the enantiomer received in a larger amount might be the opposite of the one depicted.](ao-2017-01103r_0013){#sch1}

Results and Discussion {#sec2}
======================

The basis for the fluorogenic reactions themselves lies in structural modifications, such as the generation or extension of a conjugated system within a molecule. As is apparent from the reaction scheme ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}), the transformation extends the conjugation involving the aromatic ring at the 1 position of chalcone (henceforth Ar^1^), while producing 3,5-diarylcyclohex-2-enone as the reaction product. Consequently, we planned to exploit this expanded conjugation for transforming the reaction into a fluorogenic one by proper substrate design. Accordingly, we decided to incorporate an electron-donating group (EDG) into the *para*-position of Ar^1^, thus producing an elongated electron donating--withdrawing conjugated system in the cyclohexenone product, potentially reinforcing its fluorescent output. Because an EDG at this position was expected to impede both the Michael addition and the aldol condensation steps of the annulation, we decided to counterbalance this influence by substituting the para-position of the aromatic ring at the 3-position of chalcone (henceforth Ar^2^) with an electron-withdrawing group (EWG). We expected that this substitution would facilitate the intermolecular addition step, which we assumed to be the rate-determining step of the transformation.

![Incorporation of Electron-Donating and -Withdrawing Groups in the Substrate Aimed at Generating Extended Conjugation in the Product](ao-2017-01103r_0011){#sch2}

The disubstituted chalcones, namely, (R^1^,R^2^)-chalcones, with R^1^ = OH, NH~2~, or NMe~2~ and R^2^ = NO~2~ or CN, were synthesized from the appropriate derivatives of benzaldehyde and acetophenone by a base-catalyzed aldol condensation ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}).^[@ref17]^ For obtaining the corresponding (R^1^,R^2^)-cyclohexenones (the potential products of our catalytic reaction), we applied a two-step procedure in solution (rather than the PS([l]{.smallcaps}-Val-DPEN) catalysis),^[@ref18]^ consisting of a more common Robinson annulation reaction with methyl acetoacetate, followed by hydrolysis and decarboxylation ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). Gratifyingly, both syntheses did not require a protecting group when involving a phenol substrate. On the other hand, the synthesis of (NMe~2~,NO~2~)-chalcone, unlike all of the other chalcones, entailed a separate dehydration step under acidic conditions, since the reaction between *p*-dimethylaminoacetophenone and *p*-nitrobenzaldehyde mainly afforded the addition product. Of note, with the aim of isolating the substituents' effect, we also explored monosubstituted chalcones (R^1^ = H or R^2^ = H). Noteworthy is that all of the chalcone derivatives we obtained (either disubstituted or monosubstituted) were the trans-isomers exclusively.

![Synthesis of (R^1^,R^2^)-Chalcones and (R^1^,R^2^)-Cyclohexenones](ao-2017-01103r_0012){#sch3}

When light absorption and emission of representative (R^1^,R^2^)-cyclohexenones were measured ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}), we learnt that R^1^, which is part of the cyclohexenone's conjugated system, affects the value of λ~max~ of absorption/fluorescence. As the substituent donates electrons more strongly, the compound absorbs light at a longer wavelength, with λ~max~ of absorption red-shifted to 370 nm for the most donating NMe~2~ substituent (entries 4 and 7). The data also discloses that a nitro substituent as R^2^ (and as we later discovered in any position of the chalcone) quenches fluorescence (entries 3 vs 6 and entries 4 vs 7). More importantly, the data reveals that an amino substituent as R^1^ leads to a fluorescent cyclohexenone (entries 6 and 7), as desired, with the greater fluorescence clearly being that of a tertiary amine. In other words, (NR~2~,R^2^)-chalcones (R = H or alkyl; R^2^ ≠ NO~2~) are suitable substrates for a fluorogenic reaction, especially when the amino nitrogen is alkylated. In this regard, we find it worth mentioning structurally related 7-aminocoumarins, which exhibit excellent fluorescent properties and are often used for biological and medicinal applications.^[@ref19],[@ref20]^

###### Absorbance and Fluorescence Intensities Measured for (R^1^,R^2^)-Cyclohexenones[a](#t1fn1){ref-type="table-fn"}

  entry   R^1^     R^2^    λ~max~ \[nm\][b](#t1fn2){ref-type="table-fn"}   intensity \[OD\][b](#t1fn2){ref-type="table-fn"}   λ~ex~ \[nm\][c](#t1fn3){ref-type="table-fn"}   λ~em~ \[nm\][c](#t1fn3){ref-type="table-fn"}   intensity \[RFU\][c](#t1fn3){ref-type="table-fn"}
  ------- -------- ------- ----------------------------------------------- -------------------------------------------------- ---------------------------------------------- ---------------------------------------------- ---------------------------------------------------
  1       OH       H       300                                             0.395                                              300                                            practically no fluorescence                    
  2       OH       NO~2~   300                                             0.388                                              300                                                                                           
  3       NH~2~    NO~2~   340                                             0.398                                              340                                                                                           
  4       NMe~2~   NO~2~   370                                             0.401                                              360                                                                                           
  5       OH       CN      300                                             0.295                                              300                                                                                           
  6       NH~2~    CN      340                                             0.436                                              340                                            410                                            244
  7       NMe~2~   CN      370                                             0.415                                              360                                            420                                            3481

The solutions were prepared by dissolving each cyclohexenone derivative in toluene (100 μM), and the absorbance and fluorescence were then measured using a microplate reader.

Data gathered by absorbance measurements.

Data gathered by fluorescence measurements.

Having been left with a CN group as an EWG of choice in the R^2^ position, we expanded the repertoire of potential precursors to adequate fluorogenic reporters to (NBu~2~,CN)-chalcone (in addition to (NH~2~,CN)- and (NMe~2~,CN)-chalcones), which was expected to provide better solubility in most solvents. These substrates were tested under the original catalysis conditions with PS([l]{.smallcaps}-Val-DPEN), to determine their reactivity as substrates and compare it to that of related (R^1^,H)-chalcones ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). Unfortunately, the results of these experiments revealed that the influence of the amino group in the R^1^ position causes a lowering of the reaction yield, which is not counterbalanced by the influence of the cyano group in the R^2^ position. Attempts to improve the yield, by the replacement of toluene by a different solvent, failed.

###### Yields Obtained in the Catalytic Asymmetric Robinson Annulation Reaction for Different (R^1^,R^2^)-Chalcones as Substrates[a](#t2fn1){ref-type="table-fn"}

  entry   R^1^     R^2^   yield \[%\][b](#t2fn2){ref-type="table-fn"}
  ------- -------- ------ ---------------------------------------------
  1       H        H      13
  2       H        CN     34
  3       NH~2~    CN     6
  4       NMe~2~   H      6
  5       NMe~2~   CN     10
  6       NBu~2~   H      6
  7       NBu~2~   CN     7

Reaction conditions: (R^1^,R^2^)-chalcone (1 equiv), acetone (30 equiv), PS([l]{.smallcaps}-Val-DPEN) (0.3 equiv), benzoic acid (0.2 equiv), toluene, 75 °C, 4 days.

Yields were determined according to ^1^H NMR analysis.

Because the chosen chalcones afforded very low yields (6--10%) under the conditions that already employed a high catalyst loading (30 molar %) and prolonged reaction times (4 days), it became apparent that (NR~2~,R^2^)-chalcones, in general, and (NR~2~,CN)-chalcones, in particular, could serve as substrates for screening only the most active catalysts (with PS([l]{.smallcaps}-Val-DPEN) not being one of them).

With an amino group as R^1^ being a critical element for inducing fluorescence in the product cyclohexenone, all the while decreasing the reaction rate, we sought an alternative substrate and/or reaction pathway, which would enhance the reaction yield without relinquishing fluorescence. One such proposal led to (NO~2~,H)-chalcone as our new substrate, which can be seen as an oxidized form of (NH~2~,H)-chalcone and can be converted to it, subsequent to the catalytic reaction. Satisfyingly, this substrate provided a yield of 55% in the catalytic reaction of PS([l]{.smallcaps}-Val-DPEN), as determined by ^1^H NMR analysis. We should comment that the engagement of (NO~2~,CN)-chalcone as our substrate was initially attempted because EWG as R^2^ could further enhance the reaction rate, yet the substance was found to have very low solubility in the relevant solvents. Thus, (NO~2~,H)-chalcone remained a substrate of choice. Furthermore, monitoring the reaction progress by GC analysis demonstrated that the reaction period for (NO~2~,H)-chalcone could be shortened from 4 days to merely 1 day, seeing as above 50% yield is already achieved at that point in time.

As mentioned above, choosing to employ (NO~2~,H)-chalcone as our new substrate required the adoption of a two-step approach for the coveted fluorogenic assay, adding a postcatalysis reduction step ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}). Thus, by selectively reducing the nitro group at the end of the reaction, we attained (NH~2~,H)-cyclohexenone as a detectable reporter. In spite of producing a weaker fluorophore in comparison to (NMe~2~,R^2^)-cyclohexenones, we were pleased to discover that the fluorescence still sufficed for the catalyst activity evaluation. After testing a number of reducing agents, we finally came upon tin chloride as a suitable reagent for our purpose,^[@ref21]^ since it was found to selectively reduce any nitro substrate to the corresponding amino product in a quantitative yield. Noteworthy, olefins and ketones were not affected by this reagent.

![Two-Step Methodology for Acquiring a Detectable Fluorophore Reporter\
Catalytic reaction conditions: (NO~2~,H)-chalcone (1 equiv), acetone (30 equiv), polymer-supported catalyst (0.3 equiv), benzoic acid (0.2 equiv), toluene, 75 °C, 24 h. Reduction conditions: catalytic mixture of (NO~2~,H)-cyclohexenone and leftover (NO~2~,H)-chalcone (1 equiv total), tin chloride dihydrate (10 equiv), ethanol, reflux, 40 min.](ao-2017-01103r_0007){#sch4}

The finalized protocol for testing the polymer-supported catalysts consisted of the catalytic reaction of (NO~2~,H)-chalcone with acetone, followed by easily filtering out the catalyst at the end of the reaction. A small sample of the reaction mixture can be saved at this stage for the future determination of the enantiomeric excess (e.g., by HPLC analysis with a chiral column) for the most active catalysts. The rest of the reaction mixture undergoes a procedure, which selectively reduces the nitro group to an amino group, and consequently enables us to turn to a microplate reader for fluorescence measurements ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). (NH~2~,H)-Chalcone, obtained by reducing (NO~2~,H)-chalcone (taken in an amount equivalent to that remaining in a catalytic reaction with a 0% yield), was found to have no substantial fluorescence. On the other hand, the fluorescence of (NH~2~,H)-cyclohexenone, gained by reducing (NO~2~,H)-cyclohexenone (taken in an amount equivalent to that expected for a 100% yield in the catalytic reaction), corresponds to the maximum fluorescence intensity, namely, *F*~max~. As a result, the relative intensity of fluorescence, measured for each of the reduced catalytic reaction mixtures, correlates to the relative yield of (NO~2~,H)-cyclohexenone and it therefore represents the relative activity of the catalyst.

![Fluorescence measured (λ~ex~ = 360 nm) by a microplate reader for the catalytic reaction mixture (PS([l]{.smallcaps}-Val-DPEN) catalysis) after reduction, for (NH~2~,H)-chalcone, obtained by reduction of (NO~2~,H)-chalcone and for (NH~2~,H)-cyclohexenone, gained by reduction of (NO~2~,H)-cyclohexenone.](ao-2017-01103r_0004){#fig2}

Once having found the more active catalysts, the ee measurements of the samples from the relevant catalytic reactions will be conducted. Noteworthy, despite the unfavored separation of ee and yield measurements into two different points in the protocol, we chose to measure the ee for (NO~2~,H)-cyclohexenone rather than for (NH~2~,H)-cyclohexenone because the ee measured for (NO~2~,H)-cyclohexenone is certainly unaffected by any further treatment, whereas the same could not be said a priori for (NH~2~,H)-cyclohexenone.[a](#fn1){ref-type="fn"}

Great efforts were dedicated to refining and to simplifying the new protocol as much as possible. Particularly, the reduced reaction mixture is not treated to any workup procedure and is simply diluted in ethanol to obtain a proper concentration for fluorescence measurements. This is done only after we verified that the reducing agent has no effect on the results, even though such an effect would be identical for all measurements. Furthermore, although the yield might be affected by the overall treatment, any change in yield can be expected to be roughly consistent, thus guaranteeing a proper comparison between different catalysts. Still, to ensure the credibility of the new protocol, we conducted reproducibility tests for catalysis with PS([l]{.smallcaps}-Val-DPEN) ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}) and PS([l]{.smallcaps}-Val-CHN) ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}, a catalyst that will be described shortly), which demonstrated very good reproducibility of the results.

![Reproducibility test for catalysis with PS([l]{.smallcaps}-Val-DPEN). Fluorescence was measured (λ~ex~ = 360 nm) by a microplate reader for the reduced catalytic reaction mixture in three different catalytic runs. Maximum intensities (λ~em~ = 460 nm): 142.25, 124.97, and 149.52 (σ = 10.3).](ao-2017-01103r_0008){#fig3}

![Reproducibility test for catalysis with PS([l]{.smallcaps}-Val-CHN). Fluorescence was measured (λ~ex~ = 360 nm) by a microplate reader for the reduced catalytic reaction mixture in two different catalytic runs. Maximum intensities (λ~em~ = 460 nm): 122.48 and 125.44 (σ = 1.5).](ao-2017-01103r_0006){#fig4}

Following these results, we decided to test the protocol on a small library of PS([l]{.smallcaps}-Val-DPEN)-like catalysts ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}). The members were prepared by a method analogous to that used for PS([l]{.smallcaps}-Val-DPEN) ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}).^[@ref14]^ With the urea unit and the terminal primary amine governing the catalytic activity of PS([l]{.smallcaps}-Val-DPEN), we focused on changing the amino acid on the one end of the catalyst and the chiral diamine backbone on the other end of the catalyst in the design of new resin-supported organocatalysts.

![Small library of polymer-supported organocatalysts.](ao-2017-01103r_0009){#fig5}

![Synthesis of PS([l]{.smallcaps}-Val-DPEN)](ao-2017-01103r_0001){#sch5}

This small library of catalysts chiefly came to serve a proof of concept but also to look for additional lead compounds beyond PS([l]{.smallcaps}-Val-DPEN). Hence, each of the polymer-supported catalysts was subjected to the two-step protocol, and the results are summarized in [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}. The calculated yields were attained by dividing the measured fluorescence intensity ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}, λ~ex~ = 360 nm, λ~em~ = 460 nm) by *F*~max~. As this was the first time we employed the protocol for catalyst screening, we assured the validity of the calculated yields by HPLC measurements and by ^1^H NMR analysis. The ^1^H NMR samples were prepared by evaporating the samples used for the HPLC injections, in light of the fact that the signals of the nitro derivatives are better resolved than those of the amino derivatives.

![Comparison between different resin-bound organocatalysts. Fluorescence was measured (λ~ex~ = 360 nm) by a microplate reader for the reduced catalytic reaction mixtures of each of the polymer-supported organocatalysts in our library.](ao-2017-01103r_0010){#fig6}

###### Results Gathered by Screening the Library of Catalysts According to the Two-Step Protocol[a](#t3fn1){ref-type="table-fn"}

  entry   catalyst                       yield \[%\][b](#t3fn2){ref-type="table-fn"}   yield \[%\][c](#t3fn3){ref-type="table-fn"}   yield \[%\][d](#t3fn4){ref-type="table-fn"}   ee \[%\][e](#t3fn5){ref-type="table-fn"}
  ------- ------------------------------ --------------------------------------------- --------------------------------------------- --------------------------------------------- ------------------------------------------
  1       PS([l]{.smallcaps}-Val-DPEN)   29                                            29                                            39                                            14
  2       PS([d]{.smallcaps}-Val-DPEN)   26                                            27                                            35                                            26
  3       PS([l]{.smallcaps}-Ala-DPEN)   22                                            18                                            25                                            23
  4       PS([l]{.smallcaps}-Phe-DPEN)   18                                            19                                            27                                            25
  5       PS([l]{.smallcaps}-Pgl-DPEN)   11                                            11                                            17                                            31
  6       PS([l]{.smallcaps}-Tle-DPEN)   25                                            27                                            35                                            17
  7       PS([l]{.smallcaps}-Val-CHN)    26                                            17                                            25                                            37

Reaction conditions depicted in [Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}.

Yields derived from fluorescence measurements, gained after reduction, utilizing a microplate reader.

Yields derived from HPLC measurements, obtained before reduction, based on a calibration curve for (NO~2~,H)-cyclohexenone.

Yields derived from ^1^H NMR analysis, performed before reduction, relying on the integration of (NO~2~,H)-chalcone and (NO~2~,H)-cyclohexenone.

Chromatography conditions: Chiralpak-IB column, 100% methanol, 1.5 mL/min, 294 nm. Retention times: (NO~2~,H)-chalcone, 4.1 min; (NO~2~,H)-cyclohexenone enantiomers, 6.6 min (minor) and 8.0 min (major).

Noticeably, with the exception of PS([l]{.smallcaps}-Val-CHN) (entry 7), the yields obtained by the fluorescence measurements are in accordance with the yields derived from the HPLC measurements, using a calibration curve (entries 1--6). On the other hand, ^1^H NMR analysis, which was based on the ratio of the starting material and the product alone, produced higher yields, except in the case of PS([l]{.smallcaps}-Val-CHN). A plausible explanation for this finding resides in side products, which are created in trace amounts yet accumulate to give a consistent deviation in the results.

Initially, according to the protocol, the enantiomeric excess was determined for the experiments described in entries 1, 2, 6, and 7, for which higher yields were determined using the fluorescence measurements. Eventually, because a very small library was used for this proof-of-principle experiment, the ee values for all catalytic runs were determined. Remarkably, even this small library hinted to definite trends within this group of catalysts (despite the modest differences exhibited by them) and provided us with two lead catalysts and, possibly, important insights for future studies.

Thus, within the (1*R*,2*R*)-(+)-1,2-diphenylethylenediamine (DPEN)-based series of catalysts, higher yields are associated with bulkier side chains of the amino acid residue (*^i^*Pr, *^t^*Bu), whereas higher ee values are associated with less sterically demanding side chains (Me, Bn, and Ph). Noticeably, in the nitro-Michael addition of acetone to *trans*-β-nitrostyrene, increasing the bulkiness of the amino acid enhanced the activity conclusively, much like in our case, though the ee values remained similar regardless of the group's bulkiness.^[@cit14b]^ Moreover, in the case of the nitro-Michael addition, altering the chirality of the amino acid part of the catalyst from [l]{.smallcaps} to [d]{.smallcaps} led to a great decrease in yield and a small decrease in ee. We were surprised to find that, in the current case, using the [d]{.smallcaps}-valine amino acid in the valine--DPEN catalyst afforded a similar yield and an obvious improvement in selectivity (entries 1 vs 2). This implies that a [d]{.smallcaps} configuration might be superior in our case selectivitywise and provides a better lead catalyst (probably due to the match--mismatch combination of the catalyst components).

From a comparison of the analogous DPEN-based and (1*R*,2*R*)-(−)-1,2-cyclohexanediamine (CHN)-based catalysts (entries 1 vs 7), we conclude that CHN is favored as a chiral scaffold for achieving higher enantioselectivity, whereas DPEN is preferred for enhancing the reactivity. Interestingly, the nitro-Michael addition of acetone to *trans*-β-nitrostyrene revealed the exact opposite effect.^[@cit14a]^ This finding provided an additional lead compound for future catalyst development for the enantioselective Robinson annulation.

While the screening of the set of polymer-bound catalysts demonstrated the suitability of the fluorogenic assay for lead discovery in heterogeneous catalysis, we decided to demonstrate its applicability also for the homogeneous catalysis platform. Moreover, because homogeneous catalytic systems usually demonstrate a higher activity compared to that of the heterogeneous ones, we hoped to implement a direct (one-step) fluorogenic assay rather than the two-step protocol described above, whose use was dictated by the low activity of the supported catalysts. As mentioned above, for more active catalysts, the use of less reactive (NR~2~,R^2^)-chalcones, particularly (NMe~2~,H)-chalcone, which generates a fluorescent (NMe~2~,H)-cyclohexanone reporter directly upon annulation and does not require an additional "developing" reduction step, is possible.

A set of potentially catalytic primary and secondary amines was, therefore, used as homogeneous catalysts in the fluorogenic model reaction of (NMe~2~,H)-chalcone with acetone ([Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"} and [Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}), initially without any acidic cocatalyst. The results demonstrated a complete lack of activity for all tested amines but pyrrolidine (12% yield), unequivocally pointing to pyrrolidine as the only possible catalytic candidate.^[@ref22]^ Noticeably, in one of the rare publications reporting this variant of the annulation for more reactive chalcones,^[@cit9b]^ pyrrolidine was the most reactive amine catalyst, among those examined. Taking into account that in the above-described case of polymer-supported catalysis the activity of the system was boosted up by benzoic acid, in the subsequent series of experiments, various acidic additives were used in the model reaction catalyzed by pyrrolidine ([Table [5](#tbl5){ref-type="other"}](#tbl5){ref-type="other"}). From these screening tests, *p*-nitrophenol emerged as a cocatalyst of choice, outperforming carboxylic acids, such as benzoic and acetic acids (entry 4 vs entries 2 and 3). Moreover, its activity also surpassed that of the less acidic unsubstituted phenol (entry 5) and of the substantially more acidic *o*,*p*-dinitrophenol (entry 6). Noteworthy, the attempt to use *o*,*p*-dinitrophenol or an even stronger sulfonic or phosphoric acid inhibited, or practically shut down, the catalysis (entries 6--8). Importantly, in a separate experiment, we demonstrated that nitrophenol reinforces pyrrolidine-induced catalysis but does not constitute a catalyst by itself (entry 9).

![Direct Fluorogenic Assay for the Screening of Different Combinations of Catalysts and Cocatalysts](ao-2017-01103r_0002){#sch6}

###### Experiments Employing Different Homogeneous Amine Catalysts[a](#t4fn1){ref-type="table-fn"}

  entry   catalyst                                  yield \[%\][b](#t4fn2){ref-type="table-fn"}
  ------- ----------------------------------------- ---------------------------------------------
  1       pyrrolidine                               12
  2       piperidine                                \<1
  3       morpholine                                0
  4       piperazine                                0
  5       1,4-diazabicyclo\[2.2.2\]octane (DABCO)   0
  6       *N*,*N*-dibutylamine                      0

Reaction conditions: (NMe~2~,H)-chalcone (1 equiv), catalyst (0.3 equiv), acetone (30 equiv), toluene, 75 °C, 24 h.

Yields determined according to fluorescence measurements using a microplate reader.

###### Experiments Employing Different Cocatalysts in Combination with Pyrrolidine[a](#t5fn1){ref-type="table-fn"}

  entry                               cocatalyst                                                          yield \[%\][b](#t5fn2){ref-type="table-fn"}
  ----------------------------------- ------------------------------------------------------------------- ---------------------------------------------
  1                                                                                                       12
  2                                   benzoic acid                                                        16
  3                                   acetic acid                                                         25
  4                                   *p*-nitrophenol                                                     43
  5                                   phenol                                                              27
  6                                   *o*,*p*-dinitrophenol                                               5
  7                                   camphorsulfonic acid                                                10
  8                                   binaphthyldiyl hydrogen phosphate[c](#t5fn3){ref-type="table-fn"}   \<1
  9[d](#t5fn4){ref-type="table-fn"}   *p*-nitrophenol                                                     0

Reaction conditions: (NMe~2~,H)-chalcone (1 equiv), pyrrolidine (0.3 equiv), cocatalyst (0.3 equiv), acetone (30 equiv), toluene, 75 °C, 24 h.

Yields determined according to fluorescence measurements using a microplate reader.

(*S*)-1,1′-Binaphthyl-2,2′-diyl hydrogen phosphate.

Experiment without pyrrolidine.

Once the *p*-nitrophenol cocatalytic ability was revealed, we screened again the amines we previously attempted to use as catalysts, this time in the presence of 30 molar % of *p*-nitrophenol ([Table [6](#tbl6){ref-type="other"}](#tbl6){ref-type="other"}). Although this time the formation of a trace amount of the product was observed in the experiments with some of the previously inactive amines (entries 2--4, and 6), pyrrolidine still appeared as the much more active catalyst, leading to a respectable, 43%, yield. It must be taken into account that the substrate is the least active of all of the chalcones we examined and when unsubstituted chalcone or (NO~2~,H)-chalcone was reacted under identical conditions, 83 and 98% yields, respectively, were obtained.

###### Experiments Employing Different Homogeneous Amine Catalysts in Combination with *p*-Nitrophenol[a](#t6fn1){ref-type="table-fn"}

  entry   catalyst               yield \[%\][b](#t6fn2){ref-type="table-fn"}
  ------- ---------------------- ---------------------------------------------
  1       pyrrolidine            43
  2       piperidine             4
  3       morpholine             \<1
  4       piperazine             2
  5       DABCO                  0
  6       *N*,*N*-dibutylamine   1

Reaction conditions: (NMe~2~,H)-chalcone (1 equiv), catalyst (0.3 equiv), *p*-nitrophenol (0.3 equiv), acetone (30 equiv), toluene, 75 °C, 24 h.

Yields determined according to fluorescence measurements using a microplate reader.

Encouraged by these results, we turned to the screening of various chiral derivatives of pyrrolidine with or without the nitrophenol cocatalyst ([Table [7](#tbl7){ref-type="other"}](#tbl7){ref-type="other"}). All runs were accompanied by fluorescence measurements providing the yield data, whereas HPLC analysis of the enantiomeric excess was carried out only for the yields exceeding 20%. Pyrrolidines substituted in the 3-position provided the highest yields, comparable to that of pyrrolidine itself, and their activities were affected by *p*-nitrophenol to the same extent as that of pyrrolidine (entries 1--4). Unfortunately, both (*R*)-3-aminopyrrolidine and (*R*)-3-pyrrolidinol induced very low enantiomeric excess. 2-Substituted pyrrolidines, such as [l]{.smallcaps}-proline amide, [l]{.smallcaps}-prolinol, and [l]{.smallcaps}-proline, were either inactive, even in the presence of *p*-nitrophenol (entries 5--6), or produced a racemate (entry 7). (*R*)-2-Methylpyrrolidine and (*S*)-2-(methoxymethyl)pyrrolidine, on the other hand, provided trace amounts of the product when tested alone but demonstrated significantly improved yields and noticeable enantioselectivities when paired with *p*-nitrophenol (entries 8--11). The major apparent difference between the two groups of 2-substituted pyrrolidines seems to be the hydrogen-bond-donating properties of the substituent. Although the connection between this property and the lack of catalytic activity or selectivity is not clear, it seems that both pyrrolidine derivatives of the second group provide excellent lead compounds for the development of enantioselective homogeneous catalysts for the particular variant of the Robinson annulation, which is the subject of this study.

###### Experiments Employing Chiral Pyrrolidine Derivatives[a](#t7fn1){ref-type="table-fn"}

  entry   catalyst                             cocatalyst        yield \[%\][b](#t7fn2){ref-type="table-fn"}   enantioselectivity \[%\][c](#t7fn3){ref-type="table-fn"}^,^[d](#t7fn4){ref-type="table-fn"}
  ------- ------------------------------------ ----------------- --------------------------------------------- ---------------------------------------------------------------------------------------------
  1       (*R*)-3-aminopyrrolidine                               9                                             nd
  2       (*R*)-3-aminopyrrolidine             *p*-nitrophenol   43                                            5
  3       (*R*)-3-pyrrolidinol                                   17                                            nd
  4       (*R*)-3-pyrrolidinol                 *p*-nitrophenol   44                                            4
  5       [l]{.smallcaps}-proline amide        *p*-nitrophenol   0                                             nd
  6       [l]{.smallcaps}-prolinol             *p*-nitrophenol   1                                             nd
  7       [l]{.smallcaps}-proline              *p*-nitrophenol   29                                            0
  8       (*R*)-2-methylpyrrolidine                              4                                             nd
  9       (*R*)-2-methylpyrrolidine            *p*-nitrophenol   34                                            23
  10      (*S*)-2-(methoxymethyl)pyrrolidine                     2                                             nd
  11      (*S*)-2-(methoxymethyl)pyrrolidine   *p*-nitrophenol   20                                            21

Reaction conditions: (NMe~2~,H)-chalcone (1 equiv), catalyst (0.3 equiv), cocatalyst (0.3 equiv), acetone (30 equiv), toluene, 75 °C, 24 h.

Yields determined according to fluorescence measurements using a microplate reader.

Chromatography conditions: Chiralpak-IB column, 100% methanol, 1.5 mL/min, 382 nm. Retention times: (NMe~2~,H)-chalcone, 3.9 min; (NMe~2~,H)-cyclohexenone enantiomers, 5.9 min (major) and 7.4 min (minor).

nd = not determined.

Conclusions {#sec3}
===========

In conclusion, we developed two novel fluorogenic assays for fast evaluation of catalytic efficiencies of homogeneous and heterogeneous catalysts for a variant of the Robinson annulation, which involves a simple dialkyl ketone (with two enolizable positions) and a chalcone or other enone without an α-to-carbonyl enolizable group. Furthermore, while performing a feasibility study of the assays, we were able to identify a number of catalytic systems capable of performing this cascade process in an enantioselective fashion, an achievement having only little precedent in the literature. Although the four established systems (two heterogeneous and two homogeneous) promoted the reaction with only moderate selectivity, they constitute excellent lead cases for future improvement of this enantioselective catalytic process.

Experimental Section {#sec4}
====================

General Experimental Conditions {#sec4.1}
-------------------------------

All reactions, requiring anhydrous conditions, were conducted under an atmosphere of nitrogen in oven-dried glassware in dry solvents. Thin-layer chromatography (TLC) was performed on silica gel plates, Merck 60 F~254~, and the compounds were visualized by irradiation with UV light or by staining with KMnO~4~. Flash column chromatography was carried out using silica gel Merck 60 (particle size 0.040--0.063 mm); the eluent is given in parentheses. ^1^H NMR (400 MHz) and ^13^C NMR (100 MHz) spectra were recorded on Bruker AVANCE-400 spectrometers, in dimethyl sulfoxide (DMSO)-*d*~6~ with residual DMSO-*d*~5~ (^1^H, 2.50 ppm) or DMSO-*d*~6~ (^13^C, 39.52 ppm), or in CDCl~3~ or CDCl~3~/trifluoroacetic acid (TFA) 1:1 with residual CHCl~3~ (^1^H, 7.26 ppm) or CDCl~3~ (^13^C, 77.16 ppm) as an internal standard. Gel-phase ^13^C NMR (100 MHz) spectra were recorded in benzene-*d*~6~ on Bruker AVANCE-400 spectrometers using the solvent as an internal standard (126.0 ppm). HPLC experiments were carried out using a Chiralpak-IB column on a Hitachi instrument, equipped with a UV/Vis detector, with methanol as the eluting solvent. For solid phase synthesis, yields were determined using the ^1^H NMR spectra of CDCl~3~/TFA 1:1 cleavage solutions with 34 mM 1,1,2,2-tetrachloroethane (5.95 ppm) as an internal standard.

Typical Procedure for the Preparation of Aminourea Polystyrene-Supported Catalysts {#sec4.2}
----------------------------------------------------------------------------------

### PS([l]{.smallcaps}-Val-DPEN) {#sec4.2.1}

Fmoc-[l]{.smallcaps}-Val-Wang resin (loading 0.80 mmol/g) was washed with piperidine/dimethylformamide (DMF) (20:80) (×3) for removal of the fluorenylmethyloxycarbonyl (Fmoc) protecting group. The resin was washed with DMF, tetrahydrofuran (THF), and dichloromethane (DCM) and then dried under vacuum. Phenyl chloroformate (10 equiv per amine unit), *N*,*N*-diisopropylethylamine (20 equiv per amine unit), and a catalytic amount of pyridine (0.1 equiv per amine unit) were added to a suspension of the amine-terminated resin (1 equiv) in dry THF (10 mL per 1 g resin) under a nitrogen atmosphere. The suspension was stirred at room temperature for 2 h. The resin was washed with water, THF/water, THF, and DCM and then dried under vacuum. (1*R*,2*R*)-1,2-Diphenylethane-1,2-diamine (7 equiv per amine unit) was added to a suspension of the resin (1 equiv) in dry DMF (10 mL per 1 g resin) under an atmosphere of nitrogen. The suspension was stirred at 50 °C overnight. The resin was washed with DMF/water, DMF, THF/water, THF, and DCM and then dried under vacuum.

### PS([l]{.smallcaps}/[d]{.smallcaps}-Val-phenol) Following TFA-Induced Cleavage {#sec4.2.2}

PS([l]{.smallcaps}-Val-phenol): yield 93%, loading 0.81 mmol/g. PS([d]{.smallcaps}-Val-phenol): yield 83%, loading 0.34 mmol/g. ^1^H NMR (400 MHz, CDCl~3~/TFA 1:1): δ = 7.36--7.44 (m, 2H), 7.26--7.34 (m, 1H), 7.10 (d, *J* = 8.1 Hz, 2H), 6.88 (d, *J* = 8.2 Hz, *x*H), 6.02 (d, *J* = 8.2 Hz, (1 -- *x*)H), 4.58 (dd, *J* = 8.2 Hz, *J* = 4.7 Hz, *x*H), 4.48 (dd, *J* = 8.5 Hz, *J* = 4.7 Hz, (1 -- *x*)H), 2.32--2.49 (m, 1H), 1.19 (d, *J* = 6.9 Hz, 3*x*H), 1.13 (d, *J* = 7.0 Hz, (3 -- 3*x*)H), 1.11 (d, *J* = 7.3 Hz, 3*x*H), 1.07 (d, *J* = 6.9 Hz, (3 -- 3*x*)H). ^13^C NMR (100 MHz, CDCl~3~/TFA 1:1): δ = 178.9, 178.7, 158.8, 158.0, 150.3, 150.1, 130.3, 130.2, 127.6, 127.4, 121.8, 121.7, 61.0, 60.1, 31.4, 18.9, 18.8, 17.1, 16.9.

### PS([l]{.smallcaps}-Val-DPEN) Following TFA-Induced Cleavage {#sec4.2.3}

Yield 81%, loading 0.60 mmol/g. ^1^H NMR (400 MHz, CDCl~3~/TFA 1:1): δ = 7.54 (br s, 3H), 7.23--7.37 (m, 6H), 7.15 (d, *J* = 7.0 Hz, 2H), 7.01--7.07 (m, 2H), 6.73 (br s, 2H), 5.42 (d, *J* = 10.8 Hz, 1H), 4.80 (m, 1H), 4.36 (m, 1H), 2.29 (m, 1H), 1.01 (d, *J* = 6.8 Hz, 3H), 0.96 (d, *J* = 6.8 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~/TFA 1:1): δ = 178.9, 160.4, 135.6, 132.2, 130.9, 130.0, 129.84, 129.78, 127.6, 127.3, 62.6, 59.7, 59.5, 31.2, 18.6, 17.0. Partial gel-phase ^13^C NMR (100 MHz, benzene-*d*~6~): δ = 39.0, 17.3, 16.2.

### PS([d]{.smallcaps}-Val-DPEN) Following TFA-Induced Cleavage {#sec4.2.4}

Yield 76%, loading 0.25 mmol/g. ^1^H NMR (400 MHz, CDCl~3~/TFA 1:1): δ = 8.50 (br s, 1H), 7.54 (br s, 3H), 7.10--7.37 (m, 8H), 7.01--7.06 (m, 2H), 6.75 (br s, 2H), 5.42 (d, *J* = 11.0 Hz, 1H), 4.80 (m, 1H), 4.38 (m, 1H), 2.29 (m, 1H), 1.00 (d, *J* = 6.7 Hz, 3H), 0.96 (d, *J* = 6.7 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~/TFA 1:1): δ = 179.2, 160.6, 135.6, 132.2, 131.0, 130.0, 129.9, 129.8, 127.7, 127.3, 62.6, 59.9, 59.5, 31.2, 18.6, 17.0.

### PS([l]{.smallcaps}-Val-CHN) Following TFA-Induced Cleavage {#sec4.2.5}

Yield 55%, loading 0.41 mmol/g. ^1^H NMR (400 MHz, CDCl~3~/TFA 1:1): δ = 6.93 (br s, 3H), 4.37 (m, 1H), 3.81 (m, 1H), 3.25 (m, 1H), 1.83--2.35 (m, 5H), 1.31--1.59 (m, 4H), 1.03 (d, *J* = 6.5 Hz, 3H), 0.97 (d, *J* = 6.5 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~/TFA 1:1): δ = 179.0, 160.3, 59.6, 58.0, 53.5, 32.2, 31.4, 30.4, 24.4, 23.8, 18.6, 16.9.

### PS([l]{.smallcaps}-Ala-phenol) Following TFA-Induced Cleavage {#sec4.2.6}

Yield 100%, loading 0.96 mmol/g. ^1^H NMR (400 MHz, CDCl~3~/TFA 1:1): δ = 7.36--7.43 (m, 2H), 7.26--7.33 (m, 1H), 7.09 (d, *J* = 8.2 Hz, 2H), 6.82 (d, *J* = 6.3 Hz, *x*H), 6.04 (br s, (1 -- *x*)H), 4.68 (m, *x*H), 4.58 (m, (1 -- *x*)H), 1.68 (d, *J* = 7.3 Hz, 3*x*H), 1.62 (d, *J* = 7.3 Hz, (3 -- 3*x*)H). ^13^C NMR (100 MHz, CDCl~3~/TFA 1:1): δ = 179.7, 179.6, 158.2, 157.4, 150.2, 150.0, 130.3, 130.2, 127.6, 127.4, 121.8, 121.7, 51.2, 50.5, 17.5.

### PS([l]{.smallcaps}-Ala-DPEN) Following TFA-Induced Cleavage {#sec4.2.7}

Yield 73%, loading 0.63 mmol/g. ^1^H NMR (400 MHz, CDCl~3~/TFA 1:1): δ = 8.50 (br s, 1H), 7.53 (br s, 3H), 7.22--7.38 (m, 6H), 7.16 (d, *J* = 7.1 Hz, 2H), 7.01--7.07 (m, 2H), 6.77 (br s, 2H), 5.44 (d, *J* = 11.0 Hz, 1H), 4.81 (m, 1H), 4.50 (m, 1H), 1.53 (d, *J* = 7.2 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~/TFA 1:1): δ = 180.0, 160.2, 135.6, 132.2, 131.1, 130.1, 129.8, 129.5, 127.7, 127.3, 62.5, 59.4, 50.1, 17.2.

### PS([l]{.smallcaps}-Phe-phenol) Following TFA-Induced Cleavage {#sec4.2.8}

Yield 98%, loading 0.45 mmol/g. ^1^H NMR (400 MHz, CDCl~3~/TFA 1:1): δ = 7.24--7.42 (m, 8H), 7.02 (d, *J* = 7.8 Hz, 2*x*H), 6.85 (d, *J* = 7.3 Hz, (2 -- 2*x*)H), 6.76 (d, *J* = 8.2 Hz, *x*H), 5.91 (d, *J* = 8.8 Hz, (1 -- *x*)H), 4.94 (sextet, *J* = 4.4 Hz, *x*H), 4.85 (dd, *J* = 12.9 Hz, *J* = 7.0 Hz, (1 -- *x*)H), 3.46 (dd, *J* = 14.0 Hz, *J* = 4.5 Hz, *x*H), 3.36 (dd, *J* = 14.2 Hz, *J* = 5.3 Hz, (1 -- *x*)H), 3.23 (dd, *J* = 14.2 Hz, *J* = 7.1 Hz, (1 -- *x*)H), 3.13 (dd, *J* = 14.0 Hz, *J* = 9.2 Hz, *x*H). ^13^C NMR (100 MHz, CDCl~3~/TFA 1:1): δ = 178.4, 178.2, 158.2, 157.5, 150.2, 149.9, 135.1, 134.7, 130.2, 129.7, 129.6, 128.41, 128.35, 127.6, 127.4, 121.8, 121.6, 57.0, 55.6, 38.9, 37.9.

### PS([l]{.smallcaps}-Phe-DPEN) Following TFA-Induced Cleavage {#sec4.2.9}

Yield 87%, loading 0.37 mmol/g. ^1^H NMR (400 MHz, CDCl~3~/TFA 1:1): δ = 8.51 (br s, 1H), 7.49 (br s, 3H), 6.85--7.36 (m, 15H), 6.66 (br s, 2H), 5.35 (d, *J* = 10.9 Hz, 1H), 4.78 (m, 2H), 3.28 (dd, *J* = 14.0 Hz, *J* = 4.7 Hz, 1H), 3.10 (dd, *J* = 13.9 Hz, *J* = 7.2 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~/TFA 1:1): δ = 178.5, 160.1, 135.6, 134.7, 132.2, 131.6, 131.0, 130.1, 129.8, 129.4, 128.3, 127.7, 127.4, 62.5, 59.9, 59.4, 38.1.

### PS([l]{.smallcaps}-Pgl-phenol) Following TFA-Induced Cleavage {#sec4.2.10}

Yield 92%, loading 0.58 mmol/g. ^1^H NMR (400 MHz, CDCl~3~/TFA 1:1): δ = 7.47--7.50 (m, 5H), 7.38 (t, *J* = 7.7 Hz, 2H), 7.29 (m, 1H), 7.25 (br s, *x*H), 7.10 (d, *J* = 8.2 Hz, (2 -- 2*x*)H), 7.00 (d, *J* = 8.0 Hz, 2*x*H), 6.46 (br s, (1 -- *x*)H), 5.62 (d, *J* = 6.1 Hz, *x*H), 5.53 (m, (1 -- *x*)H). ^13^C NMR (100 MHz, CDCl~3~/TFA 1:1): δ = 177.4, 177.1, 157.7, 157.1, 150.3, 150.0, 134.3, 134.0, 130.3, 130.2, 130.0, 127.7, 127.6, 127.4, 121.8, 121.7, 59.7, 58.9.

### PS([l]{.smallcaps}-Pgl-DPEN) Following TFA-Induced Cleavage {#sec4.2.11}

Yield 82%, loading 0.45 mmol/g. ^1^H NMR (400 MHz, CDCl~3~/TFA 1:1): δ = 8.50 (br s, 1H), 7.57 (br s, 3H), 7.02--7.40 (m, 15H), 6.73 (br s, 2H), 5.44 (m, 2H), 4.81 (m, 1H). ^13^C NMR (100 MHz, CDCl~3~/TFA 1:1): δ = 177.3, 159.9, 135.5, 134.3, 132.2, 131.0, 130.3, 130.2, 130.1, 130.0, 129.8, 127.7, 127.5, 127.3, 62.8, 59.6, 58.7.

### PS([l]{.smallcaps}-Tle-phenol) Following TFA-Induced Cleavage {#sec4.2.12}

Yield 100%, loading 0.74 mmol/g. ^1^H NMR (400 MHz, CDCl~3~/TFA 1:1): δ = 7.37--7.43 (m, 2H), 7.27--7.34 (m, 1H), 7.10 (d, *J* = 8.0 Hz, 2H), 6.96 (d, *J* = 8.6 Hz, *x*H), 6.11 (d, *J* = 8.7 Hz, (1 -- *x*)H), 4.45 (d, *J* = 8.5 Hz, *x*H), 4.33 (d, *J* = 9.2 Hz, (1 -- *x*)H), 1.19 (s, 9*x*H), 1.14 (s, (9 -- 9*x*)H). ^13^C NMR (100 MHz, CDCl~3~/TFA 1:1): δ = 178.3, 178.1, 158.6, 157.9, 150.4, 150.1, 130.4, 130.3, 127.7, 127.4, 121.9, 121.7, 64.5, 63.4, 35.12, 35.07, 26.2.

### PS([l]{.smallcaps}-Tle-DPEN) Following TFA-Induced Cleavage {#sec4.2.13}

Yield 87%, loading 0.59 mmol/g. ^1^H NMR (400 MHz, CDCl~3~/TFA 1:1): δ = 7.53 (br s, 3H), 7.23--7.35 (m, 6H), 7.14 (d, *J* = 7.0 Hz, 2H), 7.04 (m, 2H), 6.70 (br s, 2H), 5.39 (d, *J* = 10.9 Hz, 1H), 4.78 (m, 1H), 4.21 (s, 1H), 1.02 (s, 9H). ^13^C NMR (100 MHz, CDCl~3~/TFA 1:1): δ = 178.3, 160.3, 135.6, 132.3, 131.0, 130.0, 129.93, 129.86, 127.7, 127.3, 63.1, 62.8, 59.7, 34.8, 26.1.

Typical Procedure for the Preparation of *E*-1,3-Diarylprop-2-enone {#sec4.3}
-------------------------------------------------------------------

### *E*-3-(4-Cyanophenyl)-1-(4′-hydroxyphenyl)prop-2-enone \[i.e., (OH,CN)-Chalcone\] {#sec4.3.1}

The synthesis of the chalcone derivatives was based on the literature procedure with some modifications.^[@ref17]^*p*-Hydroxyacetophenone (1.04 g, 7.6 mmol, 1 equiv) was dissolved in a mixture of ethanol (4 mL) and aqueous sodium hydroxide (0.40 g in 6 mL of water, 10.0 mmol, 1.3 equiv). *p*-Cyanobenzaldehyde (1.00 g, 7.6 mmol, 1 equiv) was then added, and the mixture was stirred at room temperature, until TLC indicated completion of the reaction, to obtain a bright orange solid. The mixture was kept in a refrigerator overnight; thereafter, the solid was filtered and washed with a mixture of ice and water under vacuum until the washings were neutral (pH = 7). The residue was dissolved in DCM, the solution was dried over magnesium sulfate, and the solvent was removed under reduced pressure. The crude product was purified by silica gel flash column chromatography (hexanes/ethyl acetate 70:30) to give a yellow solid (1.50 g, yield 79%).

### (OH,CN)-Chalcone: *E*-3-(4-Cyanophenyl)-1-(4′-hydroxyphenyl)prop-2-enone {#sec4.3.2}

^1^H NMR (400 MHz, DMSO-*d*~6~): δ = 7.98 (d, *J* = 8.3 Hz, 2H), 7.96 (d, *J* = 15.6 Hz, 1H), 7.85 (d, *J* = 8.4 Hz, 2H), 7.78 (d, *J* = 9.1 Hz, 2H), 7.50 (d, *J* = 15.6 Hz, 1H), 6.19 (d, *J* = 9.0 Hz, 2H). ^13^C NMR (100 MHz, DMSO-*d*~6~): δ = 182.8, 177.1, 140.6, 136.8, 132.7, 132.0, 128.8, 127.0, 119.6, 119.2, 118.9, 111.1.

### (OH,NO~2~)-Chalcone: *E*-1-(4′-Hydroxyphenyl)-3-(4-nitrophenyl)prop-2-enone {#sec4.3.3}

^1^H NMR (400 MHz, DMSO-*d*~6~): δ = 8.25 (d, *J* = 8.8 Hz, 2H), 8.10 (d, *J* = 8.8 Hz, 2H), 8.06 (d, *J* = 15.6 Hz, 1H), 7.91 (d, *J* = 8.9 Hz, 2H), 7.63 (d, *J* = 15.6 Hz, 1H), 6.48 (d, *J* = 8.8 Hz, 2H). ^13^C NMR (100 MHz, DMSO-*d*~6~): δ = 184.5, 171.8, 147.5, 142.1, 137.7, 131.8, 129.3, 127.3, 123.9, 123.2, 117.7.

### (NH~2~,NO~2~)-Chalcone: *E*-1-(4′-Aminophenyl)-3-(4-nitrophenyl)prop-2-enone {#sec4.3.4}

^1^H NMR (400 MHz, DMSO-*d*~6~): δ = 8.26 (d, *J* = 8.8 Hz, 2H), 8.12 (d, *J* = 8.8 Hz, 2H), 8.06 (d, *J* = 15.6 Hz, 1H), 7.95 (d, *J* = 8.7 Hz, 2H), 7.69 (d, *J* = 15.7 Hz, 1H), 6.63 (d, *J* = 8.7 Hz, 2H), 6.24 (br s, 2H). ^13^C NMR (100 MHz, DMSO-*d*~6~): δ = 185.4, 154.2, 147.7, 141.8, 138.6, 131.4, 129.5, 126.7, 125.0, 123.9, 112.8.

### (NH~2~,CN)-Chalcone: *E*-1-(4′-Aminophenyl)-3-(4-cyanophenyl)prop-2-enone {#sec4.3.5}

^1^H NMR (400 MHz, DMSO-*d*~6~): δ = 8.04 (d, *J* = 8.4 Hz, 2H), 8.02 (d, *J* = 15.6 Hz, 1H), 7.95 (d, *J* = 8.7 Hz, 2H), 7.89 (d, *J* = 8.4 Hz, 2H), 7.64 (d, *J* = 15.6 Hz, 1H), 6.63 (d, *J* = 8.7 Hz, 2H), 6.23 (s, 2H). ^13^C NMR (100 MHz, DMSO-*d*~6~): δ = 185.5, 154.2, 139.9, 139.2, 132.7, 131.4, 129.1, 125.9, 125.1, 118.8, 112.8, 111.7.

### (NMe~2~,CN)-Chalcone: *E*-3-(4-Cyanophenyl)-1-(4′-dimethylaminophenyl)prop-2-enone {#sec4.3.6}

^1^H NMR (400 MHz, DMSO-*d*~6~): δ = 8.07 (d, *J* = 15.2 Hz, 1H), 8.07 (d, *J* = 9.0 Hz, 2H), 8.06 (d, *J* = 8.7 Hz, 2H), 7.91 (d, *J* = 8.3 Hz, 2H), 7.66 (d, *J* = 15.6 Hz, 1H), 6.77 (d, *J* = 9.1 Hz, 2H), 3.06 (s, 6H). ^13^C NMR (100 MHz, DMSO-*d*~6~): δ = 185.8, 153.5, 139.8, 139.4, 132.7, 130.9, 129.2, 125.8, 124.8, 118.7, 111.8, 110.9, 39.6.

### (NMe~2~,H)-Chalcone: *E*-1-(4′-Dimethylaminophenyl)-3-phenylprop-2-enone {#sec4.3.7}

^1^H NMR (400 MHz, CDCl~3~): δ = 8.01 (d, *J* = 9.1 Hz, 2H), 7.79 (d, *J* = 15.6 Hz, 1H), 7.64 (dd, *J* = 7.7 Hz, *J* = 1.7 Hz, 2H), 7.59 (d, *J* = 15.6 Hz, 1H), 7.35--7.44 (m, 3H), 6.71 (d, *J* = 9.1 Hz, 2H), 3.08 (s, 6H). ^13^C NMR (100 MHz, CDCl~3~): δ = 187.9, 153.6, 142.7, 135.7, 131.0, 130.1, 129.0, 128.4, 126.1, 122.3, 111.0, 40.2.

### (H,CN)-Chalcone: *E*-3-(4-Cyanophenyl)-1-phenylprop-2-enone {#sec4.3.8}

^1^H NMR (400 MHz, CDCl~3~): δ = 8.01 (d, *J* = 7.5 Hz, 2H), 7.75 (d, *J* = 15.8 Hz, 1H), 7.71 (d, *J* = 8.6 Hz, 2H), 7.67 (d, *J* = 8.6 Hz, 2H), 7.60 (d, *J* = 15.7 Hz, 1H), 7.59 (d, *J* = 7.6 Hz, 1H), 7.50 (t, *J* = 7.5 Hz, 2H). ^13^C NMR (100 MHz, CDCl~3~): δ = 189.7, 142.1, 139.2, 137.6, 133.3, 132.7, 128.84, 128.77, 128.6, 125.1, 118.4, 113.5.

### (NBu~2~,H)-Chalcone: *E*-1-(4′-Dibutylaminophenyl)-3-phenylprop-2-enone {#sec4.3.9}

^1^H NMR (400 MHz, CDCl~3~): δ = 8.00 (d, *J* = 9.1 Hz, 2H), 7.79 (d, *J* = 15.6 Hz, 1H), 7.64 (dd, *J* = 7.8 Hz, *J* = 1.6 Hz, 2H), 7.60 (d, *J* = 15.6 Hz, 1H), 7.34--7.43 (m, 3H), 6.65 (d, *J* = 9.1 Hz, 2H), 3.35 (t, *J* = 7.7 Hz, 4H), 1.61 (quin, *J* = 7.7 Hz, 4H), 1.38 (sextet, *J* = 7.4 Hz, 4H), 0.98 (t, *J* = 7.3 Hz, 6H). ^13^C NMR (100 MHz, CDCl~3~): δ = 187.4, 151.7, 142.2, 135.6, 131.1, 129.9, 128.9, 128.2, 125.2, 122.3, 110.5, 50.8, 29.4, 20.3, 14.0. HRMS (APPI-TOF) *m*/*z*: \[M + H\]^+^ calcd for C~23~H~30~NO 336.2327; found 336.2327.

### (NBu~2~,CN)-Chalcone: *E*-3-(4-Cyanophenyl)-1-(4′-dibutylaminophenyl)prop-2-enone {#sec4.3.10}

^1^H NMR (400 MHz, CDCl~3~): δ = 7.96 (d, *J* = 9.0 Hz, 2H), 7.72 (d, *J* = 15.6 Hz, 1H), 7.65--7.71 (m, 4H), 7.63 (d, *J* = 15.7 Hz, 1H), 6.64 (d, *J* = 9.1 Hz, 2H), 3.35 (t, *J* = 7.7 Hz, 4H), 1.61 (quin, *J* = 7.6 Hz, 4H), 1.38 (sextet, *J* = 7.4 Hz, 4H), 0.97 (t, *J* = 7.3 Hz, 6H). ^13^C NMR (100 MHz, CDCl~3~): δ = 186.5, 152.0, 140.2, 139.7, 132.7, 131.3, 128.5, 125.6, 124.8, 118.7, 112.8, 110.7, 50.9, 29.4, 20.4, 14.0. HRMS (APPI-TOF) *m*/*z*: \[M + H\]^+^ calcd for C~24~H~29~N~2~O 361.2280; found 361.2281.

### (NO~2~,H)-Chalcone: *E*-1-(4′-Nitrophenyl)-3-phenylprop-2-enone {#sec4.3.11}

^1^H NMR (400 MHz, CDCl~3~): δ = 8.35 (d, *J* = 8.7 Hz, 2H), 8.14 (d, *J* = 8.7 Hz, 2H), 7.84 (d, *J* = 15.7 Hz, 1H), 7.66 (m, 2H), 7.48 (d, *J* = 15.8 Hz, 1H), 7.39--7.47 (m, 3H). ^13^C NMR (100 MHz, CDCl~3~): δ = 189.2, 150.2, 147.0, 143.2, 134.4, 131.4, 129.5, 129.3, 128.8, 124.0, 121.4. HPLC analysis (Chiralpak-IB column, 100% methanol, flow rate = 1.5 mL/min, λ = 294 nm): *R*~t~ = 4.2 min.

In the case of the reaction between *p*-dimethylaminoacetophenone and *p*-nitrobenzaldehyde, the typical procedure above yielded the aldol addition product instead of the required aldol condensation product. Thus, to complete the synthesis, the addition product (1.60 g, 5.1 mmol, 1 equiv) was dissolved in ethanol (20 mL), thereafter *p*-toluenesulfonic acid monohydrate (97.0 mg, 0.51 mmol, 0.1 equiv) was added, and the solution was refluxed with stirring for 9 h. The solvent was removed under vacuum, and the residue was dissolved in DCM. The solution was washed with a saturated sodium bicarbonate solution until the aqueous layer remained basic (pH ∼ 9), dried over sodium sulfate, and evaporated to dryness. The resulting disubstituted chalcone derivative was purified by silica gel flash column chromatography (hexanes/ethyl acetate 60:40) to yield a yellow solid (1.05 g, yield 70%).

### (NMe~2~,NO~2~)-Chalcone: *E*-1-(4′-Dimethylaminophenyl)-3-(4-nitrophenyl)prop-2-enone {#sec4.3.12}

^1^H NMR (400 MHz, DMSO-*d*~6~): δ = 8.27 (d, *J* = 8.8 Hz, 2H), 8.13 (d, *J* = 8.5 Hz, 2H), 8.10 (d, *J* = 15.7 Hz, 1H), 8.07 (d, *J* = 9.3 Hz, 2H), 7.71 (d, *J* = 15.6 Hz, 1H), 6.78 (d, *J* = 9.0 Hz, 2H), 3.06 (s, 6H). ^13^C NMR (100 MHz, DMSO-*d*~6~): δ = 185.7, 153.6, 147.8, 141.8, 138.9, 131.0, 129.6, 126.6, 124.8, 123.9, 110.9, 39.7.

Typical Procedure for the Preparation of 3,5-Diarylcyclohex-2-enones {#sec4.4}
--------------------------------------------------------------------

### 3-(4′-Aminophenyl)-5-(4-cyanophenyl)cyclohex-2-enone \[i.e., (NH~2~,CN)-Cyclohexenone\] {#sec4.4.1}

The synthesis was based on the literature procedure with some modifications.^[@ref18]^*E*-1-(4′-Aminophenyl)-3-(4-cyanophenyl)prop-2-enone (1.60 g, 6.45 mmol, 1 equiv) was dissolved in ethanol (40 mL). Methyl acetoacetate (0.76 mL, 7.14 mmol, 1.1 equiv) and anhydrous barium hydroxide (0.11 g, 0.63 mmol, 0.1 equiv) were added, and the solution was stirred under reflux till TLC indicated completion of the reaction of the chalcone (hexanes/ethyl acetate 50:50). The solvents were removed under vacuum, and the residue (2.30 g) was dissolved in a mixture of glacial acetic acid (46 mL) and concentrated HCl (23 mL). The solution was refluxed with stirring for 6 h. Following cooling, the reaction was quenched by the addition of crushed ice and the obtained solution was extracted with chloroform. The organic layer was repeatedly washed with saturated sodium bicarbonate until the aqueous layer remained basic (pH ∼ 9) and dried over sodium sulfate. The solvent was removed under reduced pressure, and the crude product was purified by flash column chromatography on silica gel (hexanes/ethyl acetate 50:50) to give a yellow solid (240 mg, yield 13%).

Substances produced according to the typical procedure above are the following: (OH,H)-cyclohexenone, (OH,NO~2~)-cyclohexenone, (NH~2~,NO~2~)-cyclohexenone, (NMe~2~,NO~2~)-cyclohexenone, (OH,CN)-cyclohexenone, (NH~2~,CN)-cyclohexenone, (NMe~2~,CN)-cyclohexenone, and (NO~2~,H)-cyclohexenone. The last three of these 3,5-diarylcyclohex-2-enones were also received by catalysis with PS([l]{.smallcaps}-Val-DPEN), as will be described, whereas other 3,5-diarylcyclohex-2-enones mentioned later on were received by catalysis alone. Furthermore, the racemic (NO~2~,H)-cyclohexenone was used for HPLC preliminary experiments.

### (NH~2~,CN)-Cyclohexenone: 3-(4′-Aminophenyl)-5-(4-cyanophenyl)cyclohex-2-enone {#sec4.4.2}

Yield 6%. ^1^H NMR (400 MHz, DMSO-*d*~6~): δ = 7.82 (d, *J* = 8.3 Hz, 2H), 7.63 (d, *J* = 8.3 Hz, 2H), 7.45 (d, *J* = 8.7 Hz, 2H), 6.57 (d, *J* = 8.7 Hz, 2H), 6.33 (d, *J* = 1.5 Hz, 1H), 5.75 (s, 2H), 3.48 (m, 1H), 3.02 (dd, *J* = 17.3 Hz, *J* = 4.0 Hz, 1H), 2.87 (ddd, *J* = 17.3 Hz, *J* = 10.9 Hz, *J* = 1.8 Hz, 1H), 2.73 (dd, *J* = 15.9 Hz, *J* = 13.1 Hz, 1H), 2.47 (dd, *J* = 16.2 Hz, *J* = 3.6 Hz, 1H). ^13^C NMR (100 MHz, DMSO-*d*~6~): δ = 197.2, 158.3, 151.5, 149.9, 132.4, 128.4, 128.0, 123.6, 119.1, 119.0, 113.5, 109.4, 42.9, 40.0, 33.9. HRMS (APPI-TOF) *m*/*z*: \[M + H\]^+^ calcd for C~19~H~17~N~2~O 289.1341; found 289.1339.

### (OH,H)-Cyclohexenone: 3-(4′-Hydroxyphenyl)-5-phenylcyclohex-2-enone {#sec4.4.3}

^1^H NMR (400 MHz, CDCl~3~): δ = 7.49 (d, *J* = 8.8 Hz, 2H), 7.38 (t, *J* = 7.6 Hz, 2H), 7.30 (m, 3H), 6.88 (d, *J* = 8.7 Hz, 2H), 6.49 (d, *J* = 2.2 Hz, 1H), 5.76 (br s, 1H), 3.44 (m, 1H), 3.06 (dd, *J* = 17.3 Hz, *J* = 4.5 Hz, 1H), 2.88 (ddd, *J* = 17.6 Hz, *J* = 11.2 Hz, *J* = 2.3 Hz, 1H), 2.78 (dd, *J* = 16.4 Hz, *J* = 4.9 Hz, 1H), 2.71 (dd, *J* = 16.4 Hz, *J* = 12.52 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~): δ = 199.8, 158.7, 158.0, 143.4, 130.6, 129.0, 128.2, 127.3, 127.0, 123.4, 116.0, 44.0, 41.2, 36.3.

### (OH,NO~2~)-Cyclohexenone: 3-(4′-Hydroxyphenyl)-5-(4-nitrophenyl)cyclohex-2-enone {#sec4.4.4}

^1^H NMR (400 MHz, DMSO-*d*~6~): δ = 9.99 (s, 1H), 8.21 (d, *J* = 8.8 Hz, 2H), 7.72 (d, *J* = 8.8 Hz, 2H), 7.59 (d, *J* = 8.8 Hz, 2H), 6.82 (d, *J* = 8.8 Hz, 2H), 6.40 (d, *J* = 1.7 Hz, 1H), 3.61 (m, 1H), 3.06 (dd, *J* = 17.5 Hz, *J* = 4.5 Hz, 1H), 2.96 (ddd, *J* = 17.5 Hz, *J* = 10.7 Hz, *J* = 2.0 Hz, 1H), 2.80 (dd, *J* = 16.0 Hz, *J* = 13.2 Hz, 1H), 2.53 (dd, *J* = 16.0 Hz, *J* = 3.8 Hz, 1H). ^13^C NMR (100 MHz, DMSO-*d*~6~): δ = 197.4, 159.7, 158.0, 151.8, 146.3, 128.6, 128.2, 128.0, 123.6, 121.5, 115.6, 42.8, 39.8, 34.2. HRMS (APPI-TOF) *m*/*z*: \[M + H\]^+^ calcd for C~18~H~16~NO~4~ 310.1079; found 310.1075.

### (NH~2~,NO~2~)-Cyclohexenone: 3-(4′-Aminophenyl)-5-(4-nitrophenyl)cyclohex-2-enone {#sec4.4.5}

^1^H NMR (400 MHz, DMSO-*d*~6~): δ = 8.21 (d, *J* = 8.8 Hz, 2H), 7.72 (d, *J* = 8.8 Hz, 2H), 7.46 (d, *J* = 8.7 Hz, 2H), 6.58 (d, *J* = 8.7 Hz, 2H), 6.34 (d, *J* = 1.5 Hz, 1H), 5.74 (s, 2H), 3.56 (m, 1H), 3.05 (dd, *J* = 17.3 Hz, *J* = 4.1 Hz, 1H), 2.90 (ddd, *J* = 17.3 Hz, *J* = 10.9 Hz, *J* = 1.8 Hz, 1H), 2.76 (dd, *J* = 15.9 Hz, *J* = 13.0 Hz, 1H), 2.50 (dd, *J* = 15.4 Hz, *J* = 3.8 Hz, 1H). ^13^C NMR (100 MHz, DMSO-*d*~6~): δ = 197.1, 158.2, 152.0, 151.5, 146.3, 128.6, 128.0, 123.6, 119.1, 113.5, 42.9, 39.8, 33.9. HRMS (APPI-TOF) *m*/*z*: \[M + H\]^+^ calcd for C~18~H~17~N~2~O~3~ 309.1239; found 309.1235.

### (NMe~2~,NO~2~)-Cyclohexenone: 3-(4′-Dimethylaminophenyl)-5-(4-nitrophenyl)cyclohex-2-enone {#sec4.4.6}

^1^H NMR (400 MHz, DMSO-*d*~6~): δ = 8.20 (d, *J* = 8.8 Hz, 2H), 7.71 (d, *J* = 8.8 Hz, 2H), 7.59 (d, *J* = 9.0 Hz, 2H), 6.72 (d, *J* = 9.1 Hz, 2H), 6.40 (d, *J* = 1.6 Hz, 1H), 3.57 (m, 1H), 3.08 (dd, *J* = 17.3 Hz, *J* = 4.0 Hz, 1H), 2.96 (s, 6H), 2.92 (ddd, *J* = 17.4 Hz, *J* = 10.9 Hz, *J* = 1.9 Hz, 1H), 2.77 (dd, *J* = 16.0 Hz, *J* = 13.1 Hz, 1H), 2.51 (dd, *J* = 15.8 Hz, *J* = 3.8 Hz, 1H). ^13^C NMR (100 MHz, DMSO-*d*~6~): δ = 197.1, 157.9, 152.0, 151.7, 146.3, 128.6, 127.8, 123.6, 119.7, 111.7, 42.9, 39.9, 39.7, 33.8. HRMS (APPI-TOF) *m*/*z*: \[M + H\]^+^ calcd for C~20~H~21~N~2~O~3~ 337.1552; found 337.1548.

### (OH,CN)-Cyclohexenone: 5-(4-Cyanophenyl)-3-(4′-hydroxyphenyl)cyclohex-2-enone {#sec4.4.7}

^1^H NMR (400 MHz, DMSO-*d*~6~): δ = 10.03 (br s, 1H), 7.81 (d, *J* = 8.2 Hz, 2H), 7.63 (d, *J* = 8.3 Hz, 2H), 7.58 (d, *J* = 8.8 Hz, 2H), 6.82 (d, *J* = 8.7 Hz, 2H), 6.39 (d, *J* = 1.5 Hz, 1H), 3.52 (m, 1H), 3.03 (dd, *J* = 17.5 Hz, *J* = 4.4 Hz, 1H), 2.93 (ddd, *J* = 17.5 Hz, *J* = 10.6 Hz, *J* = 1.9 Hz, 1H), 2.76 (dd, *J* = 16.0 Hz, *J* = 13.2 Hz, 1H), 2.51 (dd, *J* = 16.6 Hz, *J* = 3.8 Hz, 1H). ^13^C NMR (100 MHz, DMSO-*d*~6~): δ = 197.6, 159.7, 158.1, 149.6, 132.5, 128.4, 128.2, 128.1, 121.5, 118.9, 115.7, 109.5, 42.8, 40.0, 34.2. HRMS (APPI-TOF) *m*/*z*: \[M + H\]^+^ calcd for C~19~H~16~NO~2~ 290.1181; found 290.1182.

### (NMe~2~,CN)-Cyclohexenone: 5-(4-Cyanophenyl)-3-(4′-dimethylaminophenyl)cyclohex-2-enone {#sec4.4.8}

Yield 10%. ^1^H NMR (400 MHz, DMSO-*d*~6~): δ = 7.82 (d, *J* = 8.4 Hz, 2H), 7.64 (d, *J* = 8.2 Hz, 2H), 7.59 (d, *J* = 9.0 Hz, 2H), 6.72 (d, *J* = 9.1 Hz, 2H), 6.40 (d, *J* = 1.6 Hz, 1H), 3.51 (m, 1H), 3.06 (dd, *J* = 17.3 Hz, *J* = 4.10 Hz, 1H), 2.97 (s, 6H), 2.91 (ddd, *J* = 17.4 Hz, *J* = 10.92 Hz, *J* = 1.9 Hz, 1H), 2.76 (dd, *J* = 16.0 Hz, *J* = 13.1 Hz, 1H), 2.49 (dd, *J* = 16.1 Hz, *J* = 4.04 Hz, 1H). ^13^C NMR (100 MHz, DMSO-*d*~6~): δ = 197.2, 158.0, 151.7, 149.8, 132.4, 128.4, 127.7, 123.7, 119.7, 118.9, 111.7, 109.5, 42.9, 40.0, 33.9, 30.7. HRMS (APPI-TOF) *m*/*z*: \[M + H\]^+^ calcd for C~21~H~21~N~2~O 317.1654; found 317.1651.

### (NO~2~,H)-Cyclohexenone: 3-(4′-Nitrophenyl)-5-phenylcyclohex-2-enone {#sec4.4.9}

Yield 55%, 14% ee. ^1^H NMR (400 MHz, CDCl~3~): δ = 8.25 (d, *J* = 8.9 Hz, 2H), 7.69 (d, *J* = 9.0 Hz, 2H), 7.39 (t, *J* = 7.4 Hz, 2H), 7.28--7.32 (m, 3H), 6.54 (d, *J* = 2.0 Hz, 1H), 3.50 (m, 1H), 3.04 (dd, *J* = 17.7 Hz, *J* = 5.5 Hz, 1H), 2.98 (ddd, *J* = 17.8 Hz, *J* = 9.9 Hz, *J* = 2.2 Hz, 1H), 2.82 (dd, *J* = 16.7 Hz, *J* = 5.2 Hz, 1H), 2.75 (dd, *J* = 16.4 Hz, *J* = 12.5 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~): δ = 198.6, 156.0, 148.3, 144.9, 142.7, 129.0, 127.6, 127.4, 127.1, 126.8, 124.0, 43.9, 40.9, 36.3. HPLC analysis (Chiralpak-IB column, 100% methanol, flow rate = 1.5 mL/min, λ = 294 nm): *R*~t~ = 6.6 min (minor), 8.0 min (major).

General Procedure for the Heterogeneously Catalyzed Asymmetric Robinson Annulation Reaction between Chalcones and Acetone {#sec4.5}
-------------------------------------------------------------------------------------------------------------------------

To a mixture of catalyst PS([l]{.smallcaps}-Val-DPEN) (0.075 mmol of the catalytic unit, 0.3 equiv) and the chalcone (0.25 mmol, 1 equiv, 0.125 M) in dry toluene (1.45 mL) were added dry acetone (0.55 mL, 7.5 mmol, 30 equiv) and benzoic acid (6.0 mg, 0.050 mmol, 0.2 equiv). The suspension was stirred at 75 °C for 4 days. After the reaction, the mixture was filtered and the resin was washed with ethyl acetate (×3). The combined organic layer was evaporated, and the yield of the product was determined by ^1^H NMR. When desired, the residue was purified by flash column chromatography on silica gel (hexanes/ethyl acetate) to afford the annulation product, whose enantiomeric excess was determined by chiral HPLC.

### (H,H)-Cyclohexenone: 3,5-Diphenylcyclohex-2-enone {#sec4.5.1}

Yield 13%. ^1^H NMR (400 MHz, CDCl~3~): δ = 7.56 (m, 2H), 7.36--7.44 (m, 5H), 7.27--7.33 (m, 3H), 6.53 (d, *J* = 2.2 Hz, 1H), 3.46 (m, 1H), 3.06 (dd, *J* = 17.7 Hz, *J* = 4.2 Hz, 1H), 2.93 (ddd, *J* = 17.7 Hz, *J* = 11.04 Hz, *J* = 2.4 Hz, 1H), 2.79 (dd, *J* = 16.5 Hz, *J* = 4.8 Hz, 1H), 2.72 (dd, *J* = 16.4 Hz, *J* = 12.7 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~): δ = 199.3, 158.8, 143.3, 138.4, 130.2, 128.9, 127.2, 126.9, 126.2, 125.2, 44.0, 41.1, 36.4.

### (NMe~2~,H)-Cyclohexenone: 3-(4′-Dimethylaminophenyl)-5-phenylcyclohex-2-enone {#sec4.5.2}

Yield 6%. Partial ^1^H NMR (400 MHz, CDCl~3~): δ = 7.52 (d, *J* = 9.0 Hz, 2H), 7.38 (m, 2H), 7.28--7.33 (m, 3H), 6.69 (d, *J* = 9.0 Hz, 2H), 6.51 (d, *J* = 2.1 Hz, 1H), 3.43 (m, 1H), 3.11 (dd, *J* = 17.4 Hz, *J* = 3.8 Hz, 1H), 3.03 (s, 6H), 2.84 (ddd, *J* = 17.4 Hz, *J* = 11.3 Hz, *J* = 2.2 Hz, 1H), 2.75 (dd, *J* = 16.4 Hz, *J* = 5.4 Hz, 1H), 2.69 (dd, *J* = 16.3 Hz, *J* = 11.9 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~): δ 199.3, 158.6, 151.9, 143.9, 128.9, 127.8, 127.1, 127.0, 124.7, 121.1, 111.8, 44.1, 41.1, 40.2, 35.8.

### (H,CN)-Cyclohexenone: 5-(4-Cyanophenyl)-3-phenylcyclohex-2-enone {#sec4.5.3}

Yield 34%. ^1^H NMR (400 MHz, CDCl~3~): δ = 7.67 (d, *J* = 8.4 Hz, 2H), 7.53--7.56 (m, 2H), 7.40--7.44 (m, 5H), 6.53 (d, *J* = 2.3 Hz, 1H), 3.54 (m, 1H), 3.08 (dd, *J* = 17.6 Hz, *J* = 3.9 Hz, 1H), 2.94 (ddd, *J* = 17.6 Hz, *J* = 10.9 Hz, *J* = 2.3 Hz, 1H), 2.78 (dd, *J* = 16.5 Hz, *J* = 4.4 Hz, 1H), 2.71 (dd, *J* = 16.3 Hz, *J* = 12.6 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~): δ = 198.1, 158.3, 148.5, 138.2, 132.9, 130.6, 129.1, 127.9, 126.3, 125.4, 118.7, 111.3, 43.4, 41.1, 35.8. HRMS (APPI-TOF) *m*/*z*: \[M + H\]^+^ calcd for C~19~H~16~NO 274.1232; found 274.1231.

### (NBu~2~,H)-Cyclohexenone: 3-(4′-Dibutylaminophenyl)-5-phenylcyclohex-2-enone {#sec4.5.4}

Yield 6%. Partial ^1^H NMR (400 MHz, CDCl~3~): δ = 6.51 (d, *J* = 1.8 Hz, 1H), 3.52 (m, 1H), 3.11 (dd, *J* = 17.3 Hz, *J* = 4.2 Hz, 1H), 2.82 (ddd, *J* = 17.3 Hz, *J* = 11.3 Hz, *J* = 1.9 Hz, 1H), 2.75 (dd, *J* = 15.4 Hz, *J* = 4.1 Hz, 1H).

### (NBu~2~,CN)-Cyclohexenone: 5-(4-Cyanophenyl)-3-(4′-dibutylaminophenyl)-cyclohex-2-enone {#sec4.5.5}

Yield 7%. Partial ^1^H NMR (400 MHz, CDCl~3~): δ = 6.49 (m, 1H), 3.45 (m, 1H), 3.08 (dd, *J* = 17.1 Hz, *J* = 4.2, Hz, 1H), 2.80 (dd, *J* = 16.6 Hz, *J* = 11.2 Hz, 1H), 2.71 (dd, *J* = 16.5 Hz, *J* = 5.0 Hz, 1H).

General Two-Step Protocol for Heterogeneous Catalyst Screening {#sec4.6}
--------------------------------------------------------------

Dry acetone (0.28 mL, 3.75 mmol, 30 equiv) was added to a mixture of the resin-supported catalyst (0.0375 mmol of the catalytic unit, 0.3 equiv), *trans*-(NO~2~,H)-chalcone (31.7 mg, 0.125 mmol, 1 equiv, 0.125 M), and benzoic acid (3.0 mg, 0.025 mmol, 0.2 equiv) in dry toluene (0.72 mL). The suspension was stirred at 75 °C for 24 h. After the reaction, the mixture was filtered through cotton wool (stoppering a glass pipette) directly into a measuring cylinder. The resin was washed with chloroform until reaching the total volume of 10.0 mL for the combined organic phase, out of which 0.5 mL (constituting 5% of the mixture) was set aside and, if determination of the enantiomeric excess was desired, was diluted 10-fold in methanol (HPLC grade). The diluted sample was directly injected into the HPLC system (Chiralpak-IB column, 100% methanol, flow rate = 1.5 mL/min, λ = 294 nm) for determining the enantiomeric excess. The remaining organic phase was evaporated under reduced pressure, and the residue (0.119 mmol total, 92 mM) was taken up in ethanol (1.29 mL). Tin chloride dihydrate (0.27 g, 1.2 mmol, 10 equiv) was then added to the mixture. The resulting solution was refluxed for 40 min and thereafter allowed to cool slightly. The somewhat warm solution was transferred to a measuring cylinder, and ethanol was added till the total volume of 100 mL was reached. The solution was diluted once more 10-fold in ethanol. The final solution was used directly for fluorescence measurements by a microplate reader (λ~ex~ = 360 nm and λ~em~ = 460 nm).

Besides catalytic attempts, utilizing the two-step protocol fully, the reduction procedure and fluorescence measurements were also performed separately as reference experiments for pure *trans*-(NO~2~,H)-chalcone (30.0 mg, 0.119 mmol, 92 mM) (equivalent to 0% yield in the catalytic reaction) and for pure racemic (NO~2~,H)-cyclohexenone (34.8 mg, 0.1186 mmol, 92 mM) (equivalent to 100% yield in the catalytic reaction).

### (NH~2~,H)-Chalcone: *E*-1-(4′-Aminophenyl)-3-phenylprop-2-enone {#sec4.6.1}

^1^H NMR (400 MHz, CDCl~3~): δ 7.90 (d, *J* = 8.6 Hz, 2H), 7.75 (d, *J* = 15.6 Hz, 1H), 7.56 (dd, *J* = 7.9 Hz, *J* = 2.6 Hz, 2H), 7.52 (d, *J* = 15.8 Hz, 1H), 7.31--7.36 (m, 3H), 6.64 (d, *J* = 8.6 Hz, 2H), 4.50 (br s, 2H). ^13^C NMR (100 MHz, CDCl~3~): δ 187.9, 151.8, 142.8, 135.1, 131.0, 129.9, 128.7, 128.1, 127.7, 122.0, 113.7.

### (NH~2~,H)-Cyclohexenone: 3-(4′-Aminophenyl)-5-phenylcyclohex-2-enone {#sec4.6.2}

^1^H NMR (400 MHz, CDCl~3~): δ 7.43 (d, *J* = 8.7 Hz, 2H), 7.37 (t, *J* = 7.3 Hz, 2H), 7.30 (t, *J* = 7.3 Hz, 3H), 6.67 (d, *J* = 8.7 Hz, 2H), 6.47 (d, *J* = 2.2 Hz, 1H), 3.72 (br s, 2H), 3.42 (m, 1H), 3.06 (dd, *J* = 17.5 Hz, *J* = 4.0 Hz, 1H), 2.84 (ddd, *J* = 17.5 Hz, *J* = 11.2 Hz, *J* = 2.2 Hz, 1H), 2.75 (dd, *J* = 16.0 Hz, *J* = 4.6 Hz, 1H), 2.69 (dd, *J* = 16.2 Hz, *J* = 12.2 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~): δ 199.5, 158.6, 148.9, 143.7, 128.9, 128.0, 127.6, 127.1, 127.0, 122.0, 114.9, 44.1, 41.2, 36.0.

General One-Step Protocol for the Screening of Homogeneous Catalytic Systems {#sec4.7}
----------------------------------------------------------------------------

Dry acetone (0.28 mL, 3.75 mmol, 30 equiv) was added to a mixture of *trans*-(NMe~2~,H)-chalcone (31.4 mg, 0.125 mmol, 1 equiv, 0.125 M), the catalyst (0.0375 mmol, 0.3 equiv of the catalytic unit), and the cocatalyst (if any, 0.00625--0.25 mmol, 0.05--2.0 equiv) in dry toluene (0.72 mL). The reaction mixture was stirred at 75 °C for 24 h. After the reaction, 20.0 mL of chloroform was added and 0.5 mL of the combined solution was set aside, if determination of the enantiomeric excess was desired. The remaining solution was diluted fivefold in chloroform. This fivefold dilution was repeated three more times. The final solution was used directly for fluorescence measurements by a microplate reader (λ~ex~ = 370 nm and λ~em~ = 460 nm).

The solution saved for the determination of the enantiomeric excess was diluted 10-fold in methanol (HPLC grade). The final diluted solution was directly injected into the HPLC system (Chiralpak-IB column, 100% methanol, flow rate = 1.5 mL/min, λ = 382 nm).

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.7b01103](http://pubs.acs.org/doi/abs/10.1021/acsomega.7b01103).NMR and HRMS spectra ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01103/suppl_file/ao7b01103_si_001.pdf))
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As measured subsequently, the enantiomeric excess is not changed upon reduction.
